• 1
    Skinner HA, Holt S, Schuller R, Roy J, Israel Y. Identification of alcohol abuse using laboratory tests and a history of trauma. Ann Intern Med 1984; 101: 84751.
  • 2
    Nilssen O, Forde OH, Brenn T. The Tromso study distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 1990; 132: 31826.
  • 3
    Nakanishi N, Suzuki K, Tatara K. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004; 27: 142732.
  • 4
    Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesäniemi YA. Gammaglutamyl transpeptidase and the metabolic syndrome. J Intern Med 2000; 248: 2308.
  • 5
    Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes 2001; 50: 184450.
  • 6
    Karp DR, Shimooku K, Lipsky PE. Expression of γ-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem 2001; 276: 3798804.
  • 7
    Lee DH, Ha MH, Kim JH et al. Gamma-glutamyltransferase and diabetes – a 4 year follow-up study. Diabetologia 2003; 46: 35964.
  • 8
    Whitfield JB. Gamma-glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263355.
  • 9
    Lee DH, Jacobs DR, Gross M et al. γ-glutamyltransferase is a predictor of incident diabetes and hypertension: the CARDIA Study. Clin Chem 2003; 49: 135866.
  • 10
    Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142: 699708.
  • 11
    Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyltransferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000; 31: 18515.
  • 12
    Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K. Serum γ-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003; 254: 28795.
  • 13
    Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P, Tuomilehto J. Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 2004; 89: 54104.
  • 14
    Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21: 7327.
  • 15
    Keil U, Liese AD, Hense HW et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984–1992. Eur Heart J 1998; 19: 1197207.
  • 16
    Meisinger C, Thorand B, Schneider A, Stieber J, Doering A, Loewel H. Sex differences in risk factors for incident type 2 diabetes mellitus. The MONICA Augsburg Cohort Study. Arch Intern Med 2002; 162: 829.
  • 17
    Chitturi S, Abeygunasekera S, Farrell GC et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 3739.
  • 18
    Yin M, Wheeler MD, Kono H et al. Essential role of tumor necrosis factor in alcohol-induced liver injury in mice. Gastroenterology 1999; 117: 94252.
  • 19
    Targher G, Seidell JC, Tonoli M, Muggeo M, De Sandre G, Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 1996; 239: 43541.
  • 20
    Thorand B, Loewel H, Schneider A et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men. Results from the MONICA Augsburg Cohort Study, 1984–1998. Arch Intern Med 2003; 163: 939.
  • 21
    Hu FB, Stampfer MJ, Solomon CG et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001; 161: 171723.
  • 22
    Stevens J, Couper D, Pankow J et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res 2001; 9: 696705.